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Abstract 
 
Background 
Measurement of post-exertion oxygen saturation has been proposed to assess illness severity in 
suspected COVID-19 infection. We aimed to determine the accuracy of post-exertional oxygen 
saturation for predicting adverse outcome in suspected COVID-19. 
 
Methods 
We undertook an observational cohort study across 70 emergency departments during first wave of 
the COVID-19 pandemic in the United Kingdom. We collected data prospectively, using a 
standardised assessment form, and retrospectively, using hospital records, from patients with 
suspected COVID-19, and reviewed hospital records at 30 days for adverse outcome (death or 
receiving organ support). Patients with post-exertion oxygen saturation recorded were selected for 
this analysis. 
 
Results 
We analysed data from 817 patients with post-exertion oxygen saturation recorded after excluding 
54 in whom measurement appeared unfeasible. The c-statistic for post-exertion change in oxygen 
saturation was 0.589 (95% confidence interval 0.465 to 0.713), and the positive and negative 
likelihood ratios of a 3% or more desaturation were respectively 1.78 (1.25 to 2.53) and 0.67 (0.46 to 
0.98). Multivariable analysis showed that post-exertion oxygen saturation was not a significant 
predictor of adverse outcome when baseline clinical assessment was taken into account (p=0.368). 
Secondary analysis excluding patients in whom post-exertion measurement appeared inappropriate 
resulted in a c-statistic of 0.699 (0.581 to 0.817), likelihood ratios of 1.98 (1.26 to 3.10) and 0.61 
(0.35 to 1.07), and some evidence of additional prognostic value on multivariable analysis (p=0.019). 
 
Conclusions 
Post-exertion oxygen saturation provides modest prognostic information in the assessment of 
patients attending the emergency department with suspected COVID-19. 
 
Registration 
ISRCTN registry, ISRCTN56149622, http://www.isrctn.com/ISRCTN28342533 
  
 . CC-BY 4.0 International licenseIt is made available under a 
perpetuity. 
 is the author/funder, who has granted medRxiv a license to display the preprint in(which was not certified by peer review)preprint 
The copyright holder for thisthis version posted August 11, 2020. .https://doi.org/10.1101/2020.08.10.20171033doi: medRxiv preprint 
3 
 
Key messages 
 
What is already known on this subject? 
x Post exertional decrease in oxygen saturation can be used to predict prognosis in chronic 
lung diseases 
x Post exertional desaturation has been proposed as a way of predicting adverse outcome in 
people with suspected COVID-19 
 
What this study adds: 
x Post-exertion oxygen saturation provides modest prognostic information in the assessment 
of patients attending the emergency department with suspected COVID-19 
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Introduction 
 
Guidelines for assessment of suspected COVID-19 recommend measurement of peripheral oxygen 
saturation to determine the severity of acute respiratory infection (1-3). Clinicians have noted that 
patients with suspected COVID-19 and a relatively normal oxygen saturation may desaturate after 
exertion, but the clinical importance of this finding is uncertain.  
 
Field walking tests are commonly used to evaluate exercise capacity and assess prognosis in chronic 
respiratory diseases (4). The lowest arterial oxygen saturation recorded during a 6-minute walk test 
is an important marker of disease severity and prognosis (5). The rapid 1-minute sit-to-stand test 
correlates with the 6-minute walk test and the severity of lung disease (6). Exertional tests have 
shown desaturation in chronic obstructive lung disease (7,8) chronic interstitial lung disease (9-11) 
and pneumocystis carinii pneumonia (12). A modified 6-minute walk test has been proposed for use 
in suspected COVID-19 infection (13) but not yet evaluated, to our knowledge. A recent review of 
rapid exercise tests for oxygen desaturation (14) identified a number of studies, as outlined above, 
but found no published studies in COVID-19. The authors suggested that a 3% drop in oxygen 
saturation on exercise was a cause for concern, based on evidence from other conditions. 
 
The Pandemic Respiratory Infection Emergency System Triage (PRIEST) study is a multicentre 
observational cohort study designed to develop and evaluate triage methods for patients with 
suspected COVID-19 infection. We added evaluation of post-exertion oxygen saturation to the aims 
of the PRIEST study in response to reports of its use in the assessment of suspected COVID-19. Our 
specific objective was to determine the accuracy of post-exertional oxygen saturation as a 
prognostic factor for 30-day adverse outcome. 
 
 
Methods 
 
We collected data from consecutive patients presenting with suspected COVID-19 infection to 70 
hospital emergency departments from 53 recruiting sites in the United Kingdom (UK). Hospitals used 
either prospective data collection, through a standardised assessment form for suspected COVID-19, 
or retrospective data collection, through research staff extracting data from hospital records onto 
the standardised form. 
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Patients were included if the assessing clinician used the standardised assessment form or recorded 
that the patient had suspected COVID-19 infection. The clinical diagnostic criteria used for suspected 
COVID-19 during the study ǁĞƌĞ ? ? ?ĨĞǀĞƌ ?ƉǇƌĞǆŝĂш ? ? ? ?ŽƌĂŚŝƐƚŽƌǇŽĨĨĞǀĞƌĂŶĚ ? ? ?ŝŶĨůƵĞŶǌĂ-like 
illness (two or more of cough, sore throat, rhinorrhoea, limb or joint pain, headache, vomiting or 
diarrhoea) or severe and/or life-threatening illness suggestive of an infectious process. We did not 
seek consent to collect data but information about the study was provided in the ED and patients 
could withdraw their data at their request. Patients with multiple presentations to hospital were 
only included once, using data from the first presentation identified by research staff. 
 
The population for this analysis was patients who had post-exertion oxygen saturation recorded as 
part of routine care. The assessing clinician made the decision to measure post-exertion oxygen 
saturation and determined the approach to achieving exertion. The study did not influence clinical 
care, so we were unable to standardise the selection of patients or the approach to measuring post-
exertion oxygen saturation. Measurement could have been undertaken deliberately, by asking the 
patient to exercise in a specified way, or opportunistically, by recording oxygen saturation after the 
patient had exerted themselves for another purpose. 
 
Research staff reviewed hospital records to identify outcomes up to 30 days after initial 
presentation. We defined patients who died or required respiratory, cardiovascular, or renal support 
as having an adverse outcome. We defined respiratory support as any intervention to protect the 
ƉĂƚŝĞŶƚ ?ƐĂŝƌǁĂǇŽƌĂƐƐŝƐƚƚŚĞŝƌǀĞŶƚŝůĂƚŝŽŶ ?ŝŶĐůƵĚŝŶŐŵĞĐŚĂŶŝĐĂůǀĞŶƚŝůĂƚŝŽŶ ?ŶŽŶ-invasive ventilation, 
or continuous positive airway pressure, but not supplemental oxygen alone or nebulised 
bronchodilators. We defined cardiovascular support as any intervention to maintain organ 
perfusion, including extra-corporeal membrane oxygenation, inotropic drugs, or invasive 
cardiovascular monitoring, but not peripheral intravenous cannulation and/or fluid administration. 
We defined renal support as any intervention to assist renal function, including haemofiltration, 
haemodialysis, or peritoneal dialysis, but not intravenous fluid administration or urinary 
catheterisation. 
 
We undertook an initial descriptive analysis of the patients with post-exertion oxygen saturation 
recorded. This identified a number of patients for whom post-exertion oxygen saturation 
measurement appeared unfeasible, based on age (less than three years), performance status 
bed/chair bound, baseline oxygen saturation below 85%, post exertion oxygen saturation below 
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50%, receiving supplemental oxygen or Glasgow Coma Score less than 14. We excluded these 
patients from the analysis. 
 
We examined baseline oxygen saturation, post-exertion oxygen saturation and post-exertion change 
in oxygen saturation (i.e. baseline minus post-exertion oxygen saturation). Analysis focused on the 
latter, because this indicates the additional value achieved by measuring oxygen saturation after 
exertion. We estimated the accuracy of each index test in terms of the sensitivity, specificity and 
likelihood ratios of each test across a range of thresholds for positivity, for predicting adverse 
outcome up to 30 days. Confidence intervals for likelihood ratios were calculated using the methods 
outlined in Koopman et al. (15) Receiving Operator Characteristic (ROC) Curves were constructed 
and the c-statistic (area under the ROC curve) was calculated for each index test. We did not attempt 
to determine an optimal threshold for positivity, because that depends upon the relative importance 
of sensitivity and specificity in the decision that post-exertion oxygen saturation is intended to 
inform. However, we decided a priori to highlight the performance of a 3% desaturation, as 
suggested by Greenhalgh et al. (14) Analysis was performed on patients with post-exertion oxygen 
saturation recorded and available 30 day outcome data, as such missing data was not imputed. 
 
To determine whether measurement of post-exertion oxygen saturation adds prognostic 
information to standard respiratory assessment, we fitted a multivariable model with age, baseline 
oxygen saturation, respiratory rate, heart rate, asthma, other chronic respiratory illness and post-
exertional oxygen saturation as covariates. 
 
We undertook a secondary analysis that excluded patients for whom post-exertion oxygen 
saturation measurement appeared less appropriate, based on age (less than 16 years), performance 
status of limited self-care, baseline oxygen saturation less than 94%, or heart rate, respiratory rate 
or systolic blood pressure scoring three points on the National Early Warning Score (NEWS2). The 
rationale for this analysis was that local guidelines (3) recommend admission for patients with 
oxygen saturation less than 94% or a score of three points or more on any NEWS2 parameter. It has 
also been suggested that post-exertional assessment is only undertaken in a patient able to stand 
safely unaided and whose resting saturation is 96% or above. (14) 
 
We planned for the PRIEST study to recruit a sample size of 20,000. The analysis presented here is a 
secondary analysis, so no sample size was pre-specified. 
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Patient and public involvement 
The Sheffield Emergency Care Forum (SECF) is a public representative group interested in emergency 
care research. [15] Members of SECF advised on the development of the PRIEST study and two 
members joined the Study Steering Committee. Patients were not involved in the recruitment to and 
conduct of the study. We are unable to disseminate the findings to study participants directly. 
 
 
 
Results 
 
The PRIEST study recruited 22485 patients across 70 hospitals between 26 March 2020 and 28 May 
2020, of whom 39 requested withdrawal of their data. We identified 874 patients who had post-
exertion oxygen saturation recorded and excluded 57 in whom measurement appeared unfeasible, 
leaving 817 for analysis. Adverse outcome occurred in 30 participants (3.7%), of these nine died, 22 
had respiratory support, five had cardiovascular support and four renal support. 
 
Supplemental Figure S1 shows the flow of patients through the study, and Supplemental Table S1 
shows the characteristics of the whole PRIEST cohort and the characteristics of those included in this 
analysis. Participants in this analysis were younger, more likely to have unrestricted performance 
status, less likely to have any comorbidities, tended to have more normal baseline physiology and 
had a much lower rate of adverse outcome.  
 
Table 1 compares the baseline oxygen saturation, post-exertion oxygen saturation and post-exertion 
change between those with and without an adverse outcome. Post-exertion oxygen saturation 
tended to be lower than baseline oxygen saturation and show a greater decrease in those who 
suffered adverse outcome (2.9% versus 1.9% mean decrease). However, Figure 1 show that oxygen 
saturations increased post-exertion in a proportion of cases and there was considerable overlap 
between those with and without adverse outcome. Supplemental Figures S2 and S3 show overlayed 
histograms for baseline and post-exertion oxygen saturation. 
 
Table 1: Comparison of index tests summary statistics between those with and without adverse 
outcome 
 
Characteristic Adverse outcome No adverse outcome All 
  (n=30) (n=787) (n=817) 
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Baseline oxygen saturation 
 N (%) 30 (100.0%) 783 (99.5%) 813 (99.5%) 
 Mean (SD) 94.5 (3.5) 97.1 (2.3) 97.0 (2.4) 
 Median (IQR) 95.0 (92.0, 97.0) 97.0 (96.0, 99.0) 97.0 (96.0, 99.0) 
Post-exertion oxygen saturation 
 N (%) 30 (100.0%) 787 (100.0%) 817 (100.0%) 
 Mean (SD) 91.6 (5.3) 95.2 (4.2) 95.0 (4.3) 
 Median (IQR) 92.0 (88.0, 96.0) 96.0 (93.0, 98.0) 96.0 (93.0, 98.0) 
Oxygen saturation difference, pre to post exercise 
 N (%) 30 (100.0%) 783 (99.5%) 813 (99.5%) 
 Mean (SD) -2.9 (5.3) -1.9 (3.5) -2.0 (3.5) 
 Median (IQR) -3.0 (-6.0, 0.0) -1.0 (-3.0, 0.0) -1.0 (-3.0, 0.0) 
 
 
Figure 2 shows the ROC curves for baseline oxygen saturation, post-exertion oxygen saturation and 
post-exertion change in oxygen saturation. The c-statistic of 0.589 for post-exertion change indicates 
poor discriminant value, partly due to post-exertion increases in oxygen saturation showing some 
association with adverse outcome. Table 2 reports sensitivity, specificity and likelihood ratios for 
thresholds of post-exertion decrease in oxygen saturation (i.e. change less than zero). The positive 
and negative likelihood ratios of a post-exertional desaturation of 3% or more were 1.78 and 0.67 
respectively, suggesting that this finding provides a small amount of additional information in 
prognostic assessment. Supplemental tables S2 and S3 show the diagnostic parameters for baseline 
and post-exertion oxygen saturation respectively. 
 
Table 2: Accuracy of post-exertion change in oxygen saturation from baseline at a range of 
thresholds for positivity, primary analysis (N=813) 
 
Threshold 
Sensitivity 
(95% CI) 
Specificity 
(95% CI) 
Positive 
likelihood ratio 
(95% CI) 
Negative 
likelihood ratio 
(95% CI) 
<=-1 
70.0 
(50.6 to 85.3) 
43.6 
(40.0 to 47.1) 
1.24 
(0.97 to 1.58) 
0.69 
(0.40 to 1.20) 
<=-2 
53.3 
(34.3 to 71.7) 
59.3 
(55.7 to 62.7) 
1.31 
(0.93 to 1.85) 
0.79 
(0.54 to 1.16) 
<=-3 
53.3 
34.3 to 71.7) 
70.1 
(66.8 to 73.3) 
1.78 
(1.25 to 2.53) 
0.67 
(0.46 to 0.98) 
<=-4 
40.0 
(22.7 to 59.4) 
77.3 
(74.2 to 80.2) 
1.76 
(1.11 to 2.78) 
0.78 
(0.58 to 1.05) 
<=-5 
36.7 
(19.9 to 56.1) 
82.2 
(79.4 to 84.9) 
2.07 
(1.26 to 3.39) 
0.77 
(0.59 to 1.01) 
<=-6 
30.0 
(14.7 to 49.4) 
86.1 
(83.5 to 88.4) 
2.16 
(1.22 to 3.83) 
0.81 
(0.64 to 1.03) 
<=-7 
23.3 
(9.9 to 42.3) 
90.5 
(88.3 to 92.5) 
2.47 
(1.25 to 4.89) 
0.85 
(0.70 to 1.04) 
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<=-8 
20.0 
(7.7 to 38.6) 
92.5 
(90.4 to 94.2) 
2.65 
(1.24 to 5.65) 
0.87 
(0.73 to 1.04) 
<=-9 
16.7 
(5.6 to 34.7) 
94.0 
(92.1 to 95.6) 
2.78 
(1.19 to 6.48) 
0.89 
(0.76 to 1.05) 
<=-10 
10.0 
(2.1 to 26.5) 
95.1 
(93.4 to 96.5) 
2.06 
(0.67 to 6.30) 
0.95 
(0.84 to 1.07) 
 
 
Figure 3 and Table 3 show comparable results for the secondary analysis excluding cases where post-
exertion oxygen saturation measurement appeared less appropriate. The c-statistic of 0.699 for 
post-exertion change in oxygen saturation indicates better discriminant value in this group. This may 
be explained by exclusion of patients with lower baseline oxygen saturations who had more 
potential to show a post-exertion change. The positive and negative likelihood ratios of a post-
exertional decrease in oxygen saturation of 3% or more were 1.98 and 0.61 respectively. 
Supplemental tables S4 and S5 show the diagnostic parameters for baseline and post-exertion 
oxygen saturation respectively for the secondary analysis. 
 
Table 3: Accuracy of post-exertion change in oxygen saturation from baseline at a range of 
thresholds for positivity, secondary analysis (N=652) 
 
Threshold 
Sensitivity 
(95% CI) 
Specificity 
(95% CI) 
Positive 
likelihood ratio 
(95% CI) 
Negative 
likelihood ratio 
(95% CI) 
<=-1 
87.5 
(61.7 to 98.4) 
44.5 
(40.6 to 48.5) 
1.58 
(1.30 to 1.93) 
0.28 
(0.08 to 1.03) 
<=-2 
56.3 
(29.9 to 80.2) 
60.4 
(56.5 to 64.2) 
1.42 
(0.91 to 2.21) 
0.72 
(0.41 to 1.26) 
<=-3 
56.3 
(29.9 to 80.2) 
71.5 
(67.9 to 75.0) 
1.98 
(1.26 to 3.10) 
0.61 
(0.35 to 1.07) 
<=-4 
43.8 
(19.8 to 70.1) 
79.1 
(75.7 to 82.2) 
2.09 
(1.18 to 3.72) 
0.71 
(0.46 to 1.10) 
<=-5 
43.8 
(19.8 to 70.1) 
83.6 
(80.5 to 86.4) 
2.68 
(1.50 to 4.80) 
0.67 
(0.43 to 1.03) 
<=-6 
31.3 
(11.0 to 58.7) 
87.1 
(84.3 to 89.6) 
2.42 
(1.14 to 5.15) 
0.79 
(0.57 to 1.10) 
<=-7 
25.0 
(7.3 to 52.4) 
91.5 
(89.1 to 93.6) 
2.94 
(1.21 to 7.13) 
0.82 
(0.62 to 1.09) 
<=-8 
25.0 
(7.3 to 52.4) 
92.8 
(90.5 to 94.7) 
3.46 
(1.42 to 8.45) 
0.81 
(0.61 to 1.08) 
<=-9 
18.8 
(4.0 to 45.6) 
94.3 
(92.2 to 96.0) 
3.31 
(1.14 to 9.63) 
0.86 
(0.68 to 1.09) 
<=-10 
12.5 
(1.6 to 38.3) 
95.8 
(93.9 to 97.2) 
2.94 
(0.76 to 11.32) 
0.91 
(0.76 to 1.10) 
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In the multivariable model on the primary analysis cohort, post-exertional oxygen saturation did not 
add prognostic value over other factors in the model (p-value for model coefficient 0.368, likelihood 
ratio test for model with and without post-exertion oxygen saturation 0.78, p=0.376). For the 
secondary analysis, post-exertional oxygen saturation added prognostic value over other factors (p-
value for model coefficient 0.019, likelihood ratio test for model with and without post-exertion 
oxygen saturation 4.82, p=0.078).  
 
 
Discussion 
Our findings suggest that measurement of post-exertion oxygen saturation adds little to clinical 
assessment of suspected COVID-19 in the emergency department. The likelihood ratios suggest that 
a desaturation of 3% or more provides a small amount of prognostic information, the c-statistic of 
0.589 for post-exertion change suggests little discriminant value, and multivariate analysis suggest 
that post-exertion oxygen saturation measurement does not add prognostic value once baseline 
measurements are taken into account. Secondary analysis suggested better discriminant value and 
some additional prognostic value when testing was limited to more appropriate cases, but likelihood 
ratios still suggested that a desaturation of 3% or more still provided only modest prognostic 
information. 
 
The observation that oxygen saturation increased post-exertion, and that some people with adverse 
outcome showed an increase, may seem surprising, but is probably explained by random variation. 
Oxygen saturation varies randomly from one measurement to the next and this variation is likely to 
be greater in sicker patients with baseline hypoxia. Thus we might expect greater variation in oxygen 
saturation to show some association with adverse outcome. 
 
Our findings suggest that measurement of post-exertion oxygen saturation provides little additional 
prognostic information in selected patients with suspected COVID-19. Greenhalgh et al suggested 
using a desaturation of at least 3% to identify cause for concern in selected patients who are well 
enough for out of hospital management. Our findings suggest that a 3% desaturation indicates small 
increase in the likelihood of adverse outcome. Further research could determine whether a more 
systematic and rigorously controlled approach to post-exertion oxygen saturation measurement can 
result in more useful prognostic information. The feasibility of such research may be limited by low 
event rates in people who are able to undertake formal post-exertion measurement of oxygen 
saturation. 
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Our study consisted of a clinically relevant population and was recruited across a wide range of 
settings, but evaluation of post-exertion oxygen saturation was a post hoc secondary analysis and 
the study was not designed specifically for this purpose. We are unable to say how patients were 
selected for measurement of post-exertion oxygen saturation, and the method for undertaking 
exertion was not standardised or recorded. We excluded 57 patients from analysis for whom post-
exertion oxygen saturation measurement appeared unfeasible, and excluded a further 162 from 
secondary analysis for whom measurement appeared less appropriate. These cases may reflect 
opportunistic oxygen saturation measurement after exertion, such as on attempting to mobilise, but 
we cannot exclude the possibility of data recording errors. Only 874 out of 22446 patients had post-
exertion oxygen saturation recorded. This may reflect limited awareness and use of post-exertion 
oxygen saturation, but may also reflect severity of illness in the emergency department population. 
Measurement of post-exertion oxygen saturation is only likely to be feasible and clinically indicated 
in those with milder illness. The relatively small number of adverse outcomes (N=30) limited the 
precision of our estimates of sensitivity and power to undertake multivariable analysis. 
 
In summary, measuring post-exertion oxygen saturation provides little prognostic information in the 
assessment of patients attending the emergency department with suspected COVID-19. 
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Figure 1: Overlayed histogram comparing post-exertion change in oxygen saturation from baseline 
between patients with and without adverse outcome (N=813) 
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Figure 2: ROC curves showing index test accuracies for predicting adverse outcome, primary 
analysis (n=817) 
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Fig 3: ROC curves showing index test accuracies for predicting adverse outcome, secondary 
analysis (N=655) 
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Supplemental Table S1: Characteristics of the PRIEST cohort and the cohort included in this 
analysis 
 
Characteristic All 
With post-
exertion oxygen 
saturation 
  (n=22446) (n=817) 
    
Sex    
 
Male 11035 (49.2%) 369 (45.2%) 
 Female 11200 (49.9%) 442 (54.1%) 
 Missing 211 (0.9%) 6 (0.7%) 
    
Ethnicity    
 
Uk\Irish\other white 15198 (67.7%) 475 (58.1%) 
 Asian 1150 (5.1%) 67 (8.2%) 
 Black/African/Caribbean 692 (3.1%) 47 (5.8%) 
 Mixed/multiple ethnic groups 328 (1.5%) 18 (2.2%) 
 Other 570 (2.5%) 47 (5.8%) 
 Missing 4508 (20.1%) 163 (20.0%) 
    
Performance status   
 
Unrestricted normal activity 11917 (53.1%) 643 (78.7%) 
 
Limited strenuous activity, can do 
light 2393 (10.7%) 83 (10.2%) 
 Limited activity, can self care 2790 (12.4%) 36 (4.4%) 
 Limited self care 2662 (11.9%) 11 (1.3%) 
 Bed/chair bound, no self care 1510 (6.7%) 0 (0.0%) 
 Missing 1174 (5.2%) 44 (5.4%) 
    
Age    
 
N (%) 22439 (100.0%) 817 (100.0%) 
 Mean (SD) 58.4 (24.2) 48.4 (16.1) 
 Median (IQR) 62.0 (43.0, 78.0) 47.0 (36.0, 59.0) 
Respiratory rate   
 
N (%) 21844 (97.3%) 796 (97.4%) 
 Mean (SD) 23.9 (7.7) 20.8 (5.3) 
 Median (IQR) 22.0 (18.0, 28.0) 20.0 (18.0, 23.0) 
Pulse Rate   
 
N (%) 21967 (97.9%) 809 (99.0%) 
 Mean (SD) 97.8 (24.5) 90.6 (18.1) 
 Median (IQR) 95.0 (81.0, 111.0) 90.0 (78.0, 102.0) 
Temperature   
 
N (%) 21741 (96.9%) 799 (97.8%) 
 Mean (SD) 37.2 (1.1) 37.0 (0.8) 
 Median (IQR) 37.0 (36.5, 37.9) 36.8 (36.5, 37.3) 
Systolic BP   
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N (%) 20698 (92.2%) 793 (97.1%) 
 Mean (SD) 134.2 (25.0) 136.5 (21.3) 
 Median (IQR) 
132.0 (117.0, 
149.0) 
134.0 (122.0, 
148.0) 
Diastolic BP   
 
N (%) 20601 (91.8%) 788 (96.5%) 
 Mean (SD) 78.0 (16.2) 82.6 (12.9) 
 Median (IQR) 78.0 (68.0, 88.0) 82.0 (74.5, 90.0) 
Oxygen saturation 
  
 
N (%) 22155 (98.7%) 813 (99.5%) 
 Mean (SD) 94.9 (6.6) 97.0 (2.4) 
 Median (IQR) 96.0 (94.0, 98.0) 97.0 (96.0, 99.0) 
    
Medical History   
No Chronic disease 7077 (31.5%) 406 (49.7%) 
Heart Disease 4723 (21.0%) 66 (8.1%) 
Renal impairment 1944 (8.7%) 27 (3.3%) 
Steroid therapy 564 (2.5%) 13 (1.6%) 
Asthma  3492 (15.6%) 135 (16.5%) 
Diabetes  4132 (18.4%) 73 (8.9%) 
Active malignancy 1124 (5.0%) 14 (1.7%) 
Immunosuppression 646 (2.9%) 30 (3.7%) 
Other chronic lung disease 3795 (16.9%) 81 (9.9%) 
Hypertension 6440 (28.7%) 155 (19.0%) 
Medical history missing 1104 (4.9%) 50 (6.1%) 
   
Adverse outcome   
Any 4698 (20.9%) 30 (3.7%) 
Death 3324 (14.8%) 9 (1.1%) 
Respiratory support 1962 (8.7%) 22 (2.7%) 
Cardiovascular support 525 (2.3%) 5 (0.6%) 
Renal support 220 (1.0%) 4 (0.5%) 
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Supplemental Table S2: Accuracy of baseline oxygen saturation at a range of thresholds for 
positivity, primary analysis (N=813) 
 
Threshold 
Sensitivity  
(95% CI) 
Specificity  
(95% CI) 
Positive likelihood 
ratio (95% CI) 
Negative likelihood 
ratio (95% CI) 
<=99 96.7 (82.8 to 99.9) 14.9 (12.5 to 17.6) 1.14 (1.06 to 1.23) 0.22 (0.03 to 1.52) 
<=98 90.0 (73.5 to 97.9) 28.6 (25.5 to 31.9) 1.26 (1.11 to 1.43) 0.35 (0.12 to 1.03) 
<=97 76.7 (57.7 to 90.1) 49.3 (45.7 to 52.9) 1.51 (1.23 to 1.86) 0.47 (0.24 to 0.90) 
<=96 70.0 (50.6 to 85.3) 66.2 (62.7 to 69.5) 2.07 (1.61 to 2.67) 0.45 (0.26 to 0.78) 
<=95 53.3 (34.3 to 71.7) 78.3 (75.2 to 81.1) 2.46 (1.72 to 3.53) 0.60 (0.41 to 0.88) 
<=94 43.3 (25.5 to 62.6) 88.5 (86.1 to 90.7) 3.77 (2.40 to 5.93) 0.64 (0.47 to 0.88) 
<=93 33.3 (17.3 to 52.8) 93.9 (92.0 to 95.4) 5.44 (3.06 to 9.67) 0.71 (0.55 to 0.92) 
<=92 30.0 (14.7 to 49.4) 95.5 (93.8 to 96.9) 6.71 (3.55 to 12.67) 0.73 (0.58 to 0.92) 
<=91 20.0 (7.7 to 38.6) 97.7 (96.4 to 98.6) 8.70 (3.72 to 20.33) 0.82 (0.69 to 0.98) 
<=90 16.7 (5.6 to 34.7) 98.5 (97.3 to 99.2) 10.87 (4.09 to 28.89 0.85 (0.72 to 1.00) 
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Supplemental Table S3: Accuracy of post-exertion oxygen saturation at a range of thresholds for 
positivity, primary analysis (N=817) 
 
Threshold 
Sensitivity  
(95% CI) 
Specificity  
(95% CI) 
Positive likelihood 
ratio (95% CI) 
Negative likelihood 
ratio (95% CI) 
<=99 100 (88.4 to 100) 9.8 (7.8 to 12.1) 1.11  0.00  
<=98 96.7 (82.8 to 99.9) 20.5 (17.7 to 23.4) 1.22 (1.13 to 1.32) 0.16 (0.02 to 1.10) 
<=97 93.3 (77.9 to 99.2) 36.7 (33.3 to 40.2) 1.47 (1.32 to 1.64) 0.18 (0.05 to 0.69) 
<=96 86.7 (69.3 to 96.2) 48.4 (44.9 to 52.0) 1.68 (1.44 to 1.96) 0.28 (0.11 to 0.70) 
<=95 66.7 (47.2 to 82.7) 58.2 (54.7 to 61.7) 1.59 (1.22 to 2.07) 0.57 (0.34 to 0.95) 
<=94 56.7 (37.4 to 74.5) 66.8 (63.4 to 70.1) 1.71 (1.23 to 2.37) 0.65 (0.43 to 0.98) 
<=93 56.7 (37.4 to 74.5) 73.4 (70.2 to 76.5) 2.13 (1.53 to 2.97) 0.59 (0.39 to 0.89) 
<=92 53.3 (34.3 to 71.7) 76.2 (73.1 to 79.2) 2.24 (1.57 to 3.20) 0.61 (0.42 to 0.90) 
<=91 43.3 (25.5 to 62.6) 81.4 (78.6 to 84.1) 2.34 (1.52 to 3.61) 0.70 (0.51 to 0.96) 
<=90 36.7 (19.9 to 56.1) 86.0 (83.4 to 88.4) 2.62 (1.59 to 4.32) 0.74 (0.56 to 0.97) 
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Table S4: Accuracy of baseline oxygen saturation at a range of thresholds for positivity, secondary 
analysis (N=652) 
 
Threshold 
Sensitivity  
(95% CI) 
Specificity  
(95% CI) 
Positive likelihood 
ratio (95% CI) 
Negative likelihood 
ratio (95% CI) 
<=99 93.8 (69.8 to 99.8) 15.1 (12.4 to 18.1) 1.10 (0.97 to 1.25) 0.41 (0.06 to 2.76) 
<=98 81.3 (54.4 to 96.0) 30.0 (26.5 to 33.8) 1.16 (0.91 to 1.48) 0.62 (0.22 to 1.73) 
<=97 68.8 (41.3 to 89.0) 52.8 (48.9 to 56.8) 1.46 (1.04 to 2.05) 0.59 (0.28 to 1.22) 
<=96 56.3 (29.9 to 80.2) 70.9 (67.2 to 74.4) 1.93 (1.23 to 3.02) 0.62 (0.35 to 1.08) 
<=95 25.0 (7.3 to 52.4) 84.3 (81.2 to 87.0) 1.59 (0.67 to 3.79) 0.89 (0.67 to 1.18) 
<=94 6.3 (0.2 to 30.2) 95.1 (93.2 to 96.7) 1.28 (0.19 to 8.81) 0.99 (0.87 to 1.12) 
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Table S5: Accuracy of post-exertion oxygen saturation at a range of thresholds for positivity, 
secondary analysis 
 
Threshold 
Sensitivity  
(95% CI) 
Specificity  
(95% CI) 
Positive likelihood 
ratio (95% CI) 
Negative likelihood 
ratio (95% CI) 
<=99 
100.0 (79.4 to 
100.0) 10.3 (8.1 to 13.0) 1.12  0.00  
<=98 93.8 (69.8 to 99.8) 21.8 (18.6 to 25.2) 1.20 (1.05 to 1.37) 0.29 (0.04 to 1.95) 
<=97 93.8 (69.8 to 99.8) 39.1 (35.3 to 43.0) 1.54 (1.34 to 1.77) 0.16 (0.02 to 1.07) 
<=96 93.8 (69.8 to 99.8) 52.1 (48.2 to 56.0) 1.96 (1.69 to 2.28) 0.12 (0.02 to 0.80) 
<=95 62.5 (35.4 to 84.8) 62.1 (58.2 to 65.9) 1.65 (1.11 to 2.44) 0.60 (0.32 to 1.13) 
<=94 50.0 (24.7 to 75.3) 71.2 (67.5 to 74.7) 1.74 (1.05 to 2.88) 0.70 (0.43 to 1.15) 
<=93 50.0 (24.7 to 75.3) 77.9 (74.5 to 81.1) 2.27 (1.36 to 3.78) 0.64 (0.39 to 1.05) 
<=92 50.0 (24.7 to 75.3) 80.9 (77.6 to 83.9) 2.62 (1.56 to 4.39) 0.62 (0.38 to 1.01) 
<=91 37.5 (15.2 to 64.6) 85.0 (82.0 to 87.7) 2.50 (1.29 to 4.83) 0.74 (0.51 to 1.08) 
<=90 37.5 (15.2 to 64.6) 89.5 (86.9 to 91.8) 3.58 (1.83 to 7.01) 0.70 (0.48 to 1.02) 
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Figure S1: Flow of patients through the study 
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Figure S2: Overlayed histogram comparing baseline oxygen saturation between patients with and 
without adverse outcome (N=813)  
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Figure S3: Overlayed histogram comparing post-exertion oxygen saturation between patients with 
and without adverse outcome (N=817)  
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